Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Baxter
Dow
McKesson

Last Updated: October 1, 2022

MEMBRANEBLUE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Membraneblue patents expire, and when can generic versions of Membraneblue launch?

Membraneblue is a drug marketed by Dorc and is included in one NDA.

The generic ingredient in MEMBRANEBLUE is trypan blue. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the trypan blue profile page.

Summary for MEMBRANEBLUE
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 39
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in MEMBRANEBLUE?MEMBRANEBLUE excipients list
DailyMed Link:MEMBRANEBLUE at DailyMed
Drug patent expirations by year for MEMBRANEBLUE
Pharmacology for MEMBRANEBLUE
Drug ClassDiagnostic Dye
Mechanism of Action Dyes

US Patents and Regulatory Information for MEMBRANEBLUE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dorc MEMBRANEBLUE trypan blue SOLUTION;OPHTHALMIC 022278-001 Feb 20, 2009 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MEMBRANEBLUE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dorc MEMBRANEBLUE trypan blue SOLUTION;OPHTHALMIC 022278-001 Feb 20, 2009 See Plans and Pricing See Plans and Pricing
Dorc MEMBRANEBLUE trypan blue SOLUTION;OPHTHALMIC 022278-001 Feb 20, 2009 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MEMBRANEBLUE

See the table below for patents covering MEMBRANEBLUE around the world.

Country Patent Number Title Estimated Expiration
Australia 715620 See Plans and Pricing
European Patent Office 1075285 EMPLOI DE COLORANT VITAL POUR FACILITER DES INTERVENTIONS CHIRURGICALES D'EXTRACTION DE LA CATARACTE (THE USE OF A VITAL DYE FOR FACILITATING SURGICAL PROCEDURES FOR CATARACT EXTRACTION) See Plans and Pricing
Japan 2012236077 USE OF TRYPAN BLUE FOR VISUALIZING ANTERIOR LENS CAPSULE OF HUMAN EYEBALL See Plans and Pricing
Austria 234118 See Plans and Pricing
Turkey 200003280 See Plans and Pricing
Australia 2003208122 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
McKinsey
Baxter
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.